On the evening of January 13, Xi’An International Medical Investment Company Limited(000516) affiliated hospitals received the handling notice from Xi\’an Health Committee, which triggered the corresponding situation of “other risk warnings for the shares of listed companies”. The trading of the company’s shares was suspended for one day from the opening of the market on January 14, 2022 and resumed from the opening of the market on January 17, 2022. Since the opening of the company’s stock market on January 17, other risk warnings have been implemented, and the stock abbreviation has been changed to “St national medicine”.
On the same day, Xi’An International Medical Investment Company Limited(000516) ( Xi’An International Medical Investment Company Limited(000516) , 000516) issued the announcement on the subordinate hospitals receiving the handling notice of Xi\’an Health Committee, which said that Xi’An International Medical Investment Company Limited(000516) subordinate Xi\’an high tech hospital (hereinafter referred to as “high tech hospital”) Xi\’an Xi’An International Medical Investment Company Limited(000516) Central Hospital (hereinafter referred to as the “Central Hospital”) received the notice of Xi\’an Health Committee on the handling of Xi\’an high tech hospital and Xi\’an Xi’An International Medical Investment Company Limited(000516) Central Hospital (hereinafter referred to as the “notice”) on January 13, 2022, and now announces the relevant information as follows:
I. main contents of the notice
After the outbreak of this round of epidemic, the high-tech hospital and the Central Hospital mechanically implemented relevant epidemic prevention policies, delayed the rescue and diagnosis and treatment of acute and dangerous patients, aroused widespread concern of public opinion and caused serious consequences. After the study of Xi’an Health Committee, the following treatment opinions are made for high tech hospital and Central Hospital:
(I) handling opinions of high tech hospital
\u3000\u30001。 Suspend business for rectification for 3 months, and reopen after rectification;
\u3000\u30002。 Give warning;
\u3000\u30003。 Instruct the high tech hospital to investigate the responsibility of the person in charge of the hospital, suspend the general manager, and remove the director of the outpatient department, the director of Obstetrics and the deputy director of the medical department;
\u3000\u30004。 The city circulated a notice of criticism, interviewed the main person in charge of the hospital, and instructed the hospital to do a good job in appeasing patients and their families.
(II) handling opinions of Central Hospital
\u3000\u30001。 Suspend business for rectification for 3 months, and reopen after rectification;
\u3000\u30002。 Give warning;
\u3000\u30003。 Instruct the central hospital to investigate the responsibility of the person in charge of the hospital, remove the legal representative and chairman of the hospital, suspend the vice president in charge and the head nurse of the outpatient department;
\u3000\u30004。 The city circulated a notice of criticism, interviewed the main person in charge of the hospital, and instructed the hospital to do a good job in appeasing the family members.
II. Impact on the company and Countermeasures
1. The company feels extremely sad, guilty and remorse for the occurrence of this incident, and expresses deep apologies to the patients and their families and the public. It will make every effort to deal with the postoperative rehabilitation treatment, appeasement and compensation of the patients and their families, deeply reflect, immediately rectify, learn lessons and hold accountable the relevant responsible persons. During the period of covid-19 pneumonia epidemic prevention and control, the two hospitals mechanically implemented relevant epidemic prevention policies, exposing weak overall awareness, false work style, weak sense of responsibility and lack of humanistic care.
2. The company’s subordinate high-tech hospitals and central hospitals will be closed for rectification from now on in strict accordance with the requirements of the circular, and properly handle the patient counseling, staff training, internal rectification and other related work under the guidance of the provincial and Municipal Health Commission. Guided by the spirit of the important instructions of Xi Jinping general secretary on people first and life first, adhere to the problem orientation, further strengthen the medical admission management of its medical institutions, compact the responsibility of medical service guarantee, optimize the diagnosis and treatment process, smooth the medical links, strengthen personnel training, improve the sense of responsibility of all staff, and resolutely put an end to any such incidents.
Under the situation that the anti epidemic and medical resources are still tight, while handling all the work in the hospital during the period of closure for rectification, the hospital continues to organize medical staff to complete the tasks of supporting patients’ treatment and community nucleic acid sampling in covid-19 designated hospitals, and coordinate the epidemic prevention and control, hospital service optimization and management improvement.
Heartfelt thanks to all sectors of society for their care, love and understanding of medical staff!
3. The suspension of the company’s subordinate high-tech hospital and central hospital for three months is expected to have a significant impact on the company’s operating performance in 2022. According to the relevant provisions of 9.1.5 and 9.8.1 of the stock listing rules of Shenzhen Stock Exchange (revised in 2022), the trading of the company’s shares will be suspended for one trading day on January 14, 2022, and other risk warnings will be implemented from the date of resumption. The company will strive to take various measures to meet the requirements of revoking other risk warnings as soon as possible. After the corresponding circumstances are eliminated, the company will timely announce and apply to Shenzhen stock exchange for revoking other risk warnings.
On January 13, Xi’An International Medical Investment Company Limited(000516) shares fell by the limit to 8.37 yuan.
